Commonwealth of Pennsylvania Public School Empls Retrmt SYS Lowers Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS cut its position in The Cooper Companies, Inc. (NASDAQ:COO) by 2.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,347 shares of the medical device company’s stock after selling 1,000 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Cooper Companies were worth $3,893,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of Cooper Companies during the 4th quarter valued at $691,000. Highland Capital Management LLC purchased a new stake in shares of Cooper Companies during the 4th quarter valued at $4,004,000. Caprock Group LLC purchased a new stake in shares of Cooper Companies during the 4th quarter valued at $282,000. Franklin Resources Inc. raised its position in shares of Cooper Companies by 194.0% during the 3rd quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock valued at $5,265,000 after buying an additional 32,260 shares in the last quarter. Finally, Principal Financial Group Inc. raised its position in shares of Cooper Companies by 6.6% during the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock valued at $26,295,000 after buying an additional 14,687 shares in the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

COO has been the topic of several recent research reports. Citigroup reduced their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Stifel Nicolaus reduced their target price on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Robert W. Baird reduced their target price on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Finally, BNP Paribas raised shares of Cooper Companies to a “hold” rating in a report on Thursday, March 13th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $81.71 on Monday. The firm has a market cap of $16.34 billion, a PE ratio of 41.90, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 12-month low of $77.05 and a 12-month high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The company’s fifty day simple moving average is $90.05 and its two-hundred day simple moving average is $98.04.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.92. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.